已发表论文

细胞周期相关 lncRNA 作为推进癌症管理的创新靶点

 

Authors Liang XR, Liu YF, Chen F, Zhou ZX, Zhang LJ, Lin ZJ

Received 6 February 2023

Accepted for publication 13 June 2023

Published 3 July 2023 Volume 2023:15 Pages 547—561

DOI https://doi.org/10.2147/CMAR.S407371

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Sanjeev K. Srivastava

Abstract: Long non-coding RNAs (lncRNAs) are non-coding RNAs (ncRNAs) longer than 200nt. They have complex biological functions and take part in multiple fundamental biological processes, such as cell proliferation, differentiation, survival and apoptosis. Recent studies suggest that lncRNAs modulate critical regulatory proteins involved in cancer cell cycle, such as cyclin, cell cycle protein-dependent kinases (CDK) and cell cycle protein-dependent kinase inhibitors (CKI) through different mechanisms. To clarify the role of lncRNAs in the regulation of cell cycle will provide new ideas for design of antitumor therapies which intervene with the cell cycle progression. In this paper, we review the recent studies about the controlling of lncRNAs on cell cycle related proteins such as cyclin, CDK and CKI in different cancers. We further outline the different mechanisms involved in this regulation and describe the emerging role of cell cycle-related lncRNAs in cancer diagnosis and therapy.
Keywords: cyclin, cyclin-CDK, CDK inhibitors, lncRNA